Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling. (Q52888457)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

title

Apoptosis induction by SAHA in cutaneous T-cell lymphoma cells is related to downregulation of c-FLIP and enhanced TRAIL signaling (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

author name string

Nadya Al-Yacoub

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Lothar F Fecker

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Michael Plötz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Frank K Braun

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Wolfram Sterry

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

Jürgen Eberle

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

language of work or name

English

0 references

publication date

3 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

Journal of Investigative Dermatology

31 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

volume

132

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

31 January 2020

page(s)

2263-2274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22551975%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/jid.2012.125

31 January 2020

exact match

0 references

cites work

Depsipeptide (FR901228) induces histone acetylation and inhibition of histone deacetylase in chronic lymphocytic leukemia cells concurrent with activation of caspase 8-mediated apoptosis and down-regulation of c-FLIP protein

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/Tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL).

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Anticancer activities of histone deacetylase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Rational combinations using HDAC inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Nonsteroidal anti-inflammatory drugs induce apoptosis in cutaneous T-cell lymphoma cells and enhance their sensitivity for TNF-related apoptosis-inducing ligand

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Resistance of cutaneous anaplastic large-cell lymphoma cells to apoptosis by death ligands is enhanced by CD30-mediated overexpression of c-FLIP.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Histone deacetylase inhibitors in Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

The histone deacetylase inhibitor suberoylanilide hydroxamic acid sensitises human hepatocellular carcinoma cells to TRAIL-induced apoptosis by TRAIL-DISC activation.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Resistance to FasL and tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in Sezary syndrome T-cells associated with impaired death receptor and FLICE-inhibitory protein expression

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

IAPs: more than just inhibitors of apoptosis proteins

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Overcoming apoptosis deficiency of melanoma-hope for new therapeutic approaches

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Human cutaneous T cell lymphoma and leukemia cell lines produce and respond to T cell growth factor

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Caspase-3 triggers a TPCK-sensitive protease pathway leading to degradation of the BH3-only protein puma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Inhibition of death receptor signals by cellular FLIP

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Establishment of two continuous T-cell strains from a single plaque of a patient with mycosis fungoides

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

A continuous T-cell line from a patient with Sézary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

HR23B is a biomarker for tumor sensitivity to HDAC inhibitor-based therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Drug Insight: histone deacetylase inhibitor-based therapies for cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Life and death in peripheral T cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Histone deacetylase inhibitors in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

A phase II trial of vorinostat (suberoylanilide hydroxamic acid) in metastatic breast cancer: a California Cancer Consortium study

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

NF-kappaB signals induce the expression of c-FLIP.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Extrinsic pathway- and cathepsin-dependent induction of mitochondrial dysfunction are essential for synergistic flavopiridol and vorinostat lethality in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

HDAC inhibitors with different gene regulation activities depend on the mitochondrial pathway for the sensitization of leukemic T cells to TRAIL-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Bcl-2-family proteins and hematologic malignancies: history and future prospects

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Molecular mechanisms of caspase regulation during apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingomyelinase-dependent generation of ceramide

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Proteome analyses of the growth inhibitory effects of NCH-51, a novel histone deacetylase inhibitor, on lymphoid malignant cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis, down-regulates the CXCR4 chemokine receptor and impairs migration of chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Establishment of an IL-2 independent, human T-cell line possessing only the p70 IL-2 receptor

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Genomic loss of the putative tumor suppressor gene E2A in human lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

HDAC inhibitor-based therapies and haematological malignancy

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Effective caspase inhibition blocks neutrophil apoptosis and reveals Mcl-1 as both a regulator and a target of neutrophil caspase activation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

WHO-EORTC classification for cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Vorinostat interferes with the signaling transduction pathway of T-cell receptor and synergizes with phosphoinositide-3 kinase inhibitors in cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Low FAS/CD95 expression by CTCL correlates with reduced sensitivity to apoptosis that can be restored by FAS upregulation

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

The BCL-2 protein family: opposing activities that mediate cell death

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021

Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells.

1 reference

https://api.crossref.org/works/10.1038%2FJID.2012.125

7 January 2021